semaglutide
Semaglutide vs Tirzepatide-503B Bulks Aftermath
Semaglutide vs Tirzepatide-503B Bulks Aftermath In 2026, the FDA’s removal of semaglutide from the 503B bulk program sent hospital pharmacy costs soaring, while tirzepatide and liraglutide now face their own pricing adjustments. Imagine your hospital buys 50,000 units of semaglutide monthly - now it’s confronting a steep